The primary goal of this study is to evaluate the short-term safety and potential efficacy of
oyster mushrooms (Pleurotus ostreatus) for treatment of hyperlipidemia in HIV-infected
patients who are taking Kaletra, a protease inhibitor (PI) that is commonly used in highly
active antiretroviral therapy (HAART).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)